How to Get Addyi (Flibanserin) in Missouri

What Addyi Is and Why It Requires a Special Prescribing Process

Flibanserin (Addyi) is the only FDA-approved non-hormonal treatment for generalized acquired HSDD in premenopausal women. It works as a serotonin 1A agonist and serotonin 2A antagonist, targeting central neurotransmitter pathways rather than hormones. The FDA approved flibanserin in August 2015 under a Risk Evaluation and Mitigation Strategy (REMS) that was later modified. [1]

The REMS originally required prescriber certification and pharmacy enrollment, but the FDA updated those requirements over subsequent years. As of the current labeling, the central prescribing restriction that remains is the alcohol contraindication. Patients must be counseled to avoid all alcohol because the combination significantly increases risk of hypotension and syncope. [1]

The BEGONIA trial (N=1,378, published in the Journal of Sexual Medicine, 2014) demonstrated that flibanserin 100 mg nightly increased the number of satisfying sexual events (SSEs) by a mean of 2.5 events per month above baseline versus 1.5 for placebo over 24 weeks, with a statistically significant difference (P<0.001). [2] Desire scores on the Female Sexual Function Index improved by 1.0 point on a 6-point scale versus 0.7 for placebo. [2]

Because HSDD has historically been under-treated, the FDA has emphasized access. [3] Missouri's telemedicine statutes align with that goal, allowing remote evaluation and e-prescribing of flibanserin by qualified clinicians. [4]

Clinical Eligibility: Who Qualifies for Addyi in Missouri

A Missouri clinician will confirm four eligibility criteria before prescribing. First, the patient must be a premenopausal woman. Second, the HSDD must be generalized (not limited to specific situations or partners) and acquired (developed after a period of normal desire). Third, the low desire must cause marked personal distress or interpersonal difficulty. Fourth, the distress must not be fully explained by a comorbid medical condition, a medication side effect, or a relationship problem. [1]

Clinicians use validated tools to establish diagnosis and distress. The Female Sexual Distress Scale-Revised (FSDS-R) score of 11 or higher indicates clinically meaningful distress and appears in published HSDD diagnostic literature. [5] A score on the Female Sexual Function Index (FSFI) desire domain below 3.3 out of 6.0 correlates with HSDD in research populations. [6]

Contraindications must be screened before prescribing. Absolute contraindications include current alcohol use (patients must commit to abstinence), use of strong CYP3A4 inhibitors such as fluconazole, ketoconazole, clarithromycin, ritonavir, or nefazodone, and use of moderate CYP3A4 inhibitors including ciprofloxacin, fluoxetine, and grapefruit juice. [1] Liver impairment of any degree also contraindicates use. [1]

The FDA label states directly: "Alcohol use is contraindicated in patients taking flibanserin." [1] That single sentence drives the majority of prescriber screening questions at intake.

Postmenopausal women and men are not approved populations. Prescribing for those groups is off-label, and Missouri insurers and most cash-pay platforms restrict access accordingly.

Labs and Testing Needed Before Getting a Prescription in Missouri

No mandatory laboratory panel is required by FDA labeling before initiating flibanserin. However, responsible Missouri prescribers routinely order a targeted workup to rule out reversible hormonal or medical causes of low desire and to confirm there are no contraindications. [7]

Recommended baseline tests include a comprehensive metabolic panel (CMP) to assess liver function, since hepatic impairment contraindicates flibanserin. [1] Thyroid-stimulating hormone (TSH) testing rules out hypothyroidism, a common driver of low libido. [7] A complete blood count and fasting glucose screen for conditions that affect sexual function systemically. Estradiol and FSH levels can help confirm premenopausal status in women with irregular cycles or perimenopause concerns. [8]

Some Missouri telehealth platforms also check free testosterone and DHEA-S to assess androgen status, since androgen deficiency independently reduces sexual desire and may need separate treatment. [9] That panel is not required by the FDA but reflects best-practice endocrine evaluation. [9]

Medication reconciliation is as important as labs. A prescriber will review every current drug for CYP3A4 inhibitor status before approving flibanserin. [1] This review can happen entirely via telehealth chart review if the patient brings a current medication list.

How to Get an Addyi Prescription in Missouri: Step-by-Step

Getting flibanserin in Missouri follows a predictable path. The process takes three to seven business days from first contact to medication in hand for most patients.

Step 1. Choose an in-person or telehealth prescriber. Missouri law permits synchronous audio-visual telehealth visits for new patient evaluations and flibanserin prescribing. [4] Missouri-licensed telehealth platforms can conduct a full intake, collect a medication list, review uploaded lab results, and transmit an e-prescription to a Missouri-licensed pharmacy. In-person visits at OB-GYN, primary care, or sexual medicine practices remain an option for patients who prefer them.

Step 2. Complete the intake questionnaire. Most platforms send a validated HSDD screening form, an FSDS-R or FSFI, and a medication and alcohol use questionnaire before the synchronous visit. Completing these forms honestly shortens the visit and improves documentation for any future insurance or prior authorization submission.

Step 3. Attend the clinical visit. The prescriber will confirm the HSDD diagnosis, discuss alcohol abstinence in detail, screen for CYP3A4 inhibitor use, and review liver status. The visit typically runs 20 to 40 minutes. [10]

Step 4. Receive the prescription. Flibanserin is Schedule IV in some states, but Missouri has not placed it on a state controlled substance schedule, so standard electronic prescribing applies. [4] The prescriber sends the e-prescription directly to a pharmacy of the patient's choice or to a mail-order pharmacy that ships within Missouri.

Step 5. Fill at a retail or mail-order pharmacy. Most major pharmacy chains in Missouri stock or can special-order branded Addyi. Mail-order pharmacies licensed in Missouri typically ship within two to three business days after verifying the prescription. If the branded product is unavailable or cost-prohibitive, a Missouri-licensed 503A compounding pharmacy can prepare flibanserin 100 mg tablets upon receipt of a valid patient-specific prescription. [11]

Step 6. Start at bedtime and track outcomes. The prescriber will reassess at four to eight weeks. If no benefit appears after eight weeks of consistent nightly dosing, the FDA label recommends discontinuation. [1]

Telehealth Providers in Missouri Prescribing Addyi

Missouri adopted telehealth-friendly prescribing rules that allow a prescription to be issued after a real-time audio-visual evaluation even without a prior in-person relationship, provided the standard of care is met. [4] This aligns Missouri with the majority of states following the COVID-era expansion of telehealth authority.

A HealthRX clinician conducting a Missouri telehealth visit for flibanserin will verify state licensure, confirm the platform uses HIPAA-compliant video, and document that the patient resides in Missouri at the time of the visit. The prescriber cannot issue a prescription if the patient is physically outside Missouri at appointment time, even if they are a Missouri resident.

The American College of Obstetricians and Gynecologists (ACOG) supports telemedicine as an appropriate modality for sexual health consultations when a proper clinical evaluation is conducted. [12] That guidance directly supports telehealth flibanserin prescribing in Missouri.

Patients should verify that their chosen telehealth provider holds an active Missouri medical, nursing, or physician assistant license. The Missouri Division of Professional Registration maintains a public license verification portal. A provider licensed only in another state cannot legally prescribe to a Missouri-based patient.

Who Can Prescribe Addyi in Missouri: MD, NP, and PA Prescribing Authority

Any Missouri-licensed prescriber with appropriate authority can prescribe flibanserin. That includes MDs, DOs, nurse practitioners with full practice authority, and physician assistants operating under a collaborative practice arrangement. [13]

Missouri granted nurse practitioners full independent practice authority for established patients but requires physician oversight agreements for new patient prescribing in some clinical settings. Practically, most NPs prescribing flibanserin in Missouri operate under a collaborative agreement with an MD or DO, which satisfies state requirements and insurer credentialing needs. [13]

Physician assistants in Missouri require a written collaborative practice agreement with a supervising physician. That agreement must specify the scope of practice, and HSDD pharmacotherapy falls within the scope for most OB-GYN and primary care PA arrangements.

Specialties most likely to prescribe flibanserin in Missouri include OB-GYN, internal medicine, family medicine, and sexual medicine. Psychiatrists occasionally prescribe it when HSDD co-exists with treated depression, though the serotonergic interaction profile with SSRIs and SNRIs demands close review. [14] Combining flibanserin with SSRIs is not absolutely contraindicated by label, but pharmacodynamic interaction data are limited. [1]

Addyi Pharmacies in Missouri: Retail, Mail-Order, and 503A Compounding

Brand-name Addyi 100 mg tablets are available at retail pharmacies across Missouri. Large chains including CVS, Walgreens, and Walmart pharmacies can dispense Addyi with a valid prescription. Because stock levels vary by location, patients benefit from calling ahead or using the pharmacy's app to confirm availability.

Mail-order dispensing is legal in Missouri. A Missouri-licensed mail-order pharmacy can fill a 30-day or 90-day supply and ship directly to the patient's home. Shipping typically takes two to three business days via standard carriers.

Missouri-licensed 503A compounding pharmacies can legally compound flibanserin for individual patients under a patient-specific prescription from a licensed prescriber. [11] The 503A designation means the pharmacy compounds for specific named patients, not in bulk. Compounded flibanserin is typically priced lower than the brand, though it lacks FDA approval for bioequivalence and quality data. Patients choosing a compounding route should confirm the pharmacy holds current Missouri Board of Pharmacy licensure and USP 795 compliance documentation. [11]

Missouri Medicaid does not cover Addyi for HSDD. The state's Medicaid formulary covers flibanserin only for Type 2 diabetes, an off-label indication that does not apply to most HSDD patients. Cash-pay pricing for brand Addyi runs approximately $800 to $1,000 per month at full retail. Sprout Pharmaceuticals maintains a savings card program that can reduce out-of-pocket costs to around $99 per month for eligible commercially insured or uninsured patients. [15]

Prior Authorization Requirements in Missouri for Addyi

Missouri commercial insurers that cover Addyi typically require prior authorization. Required documentation commonly includes a DSM-5-aligned HSDD diagnosis with documented duration of at least six months, evidence of personal distress (FSDS-R score documentation), a list of prior treatments tried and failed (including psychotherapy or relationship counseling in some plans), confirmation of premenopausal status, and a statement that the prescriber has counseled the patient on alcohol abstinence. [16]

Premenopausal status documentation may require an estradiol and FSH result or a gynecologic note confirming regular menses.

Some Missouri commercial plans also require that the prescribing clinician be an OB-GYN or sexual medicine specialist rather than a primary care provider. Patients whose primary care provider submitted the initial PA may need a specialist co-signature.

The typical PA review timeline in Missouri is 3 to 14 business days. Urgent PA processes can complete in 72 hours when the prescriber submits a clinical urgency attestation.

If PA is denied, a prescriber can file a peer-to-peer review request within 30 days in most Missouri plans. The peer-to-peer review involves a direct conversation between the treating clinician and the plan's medical director, and approval rates at peer-to-peer are meaningfully higher than first-submission rates. [16]

Transferring an Existing Addyi Prescription to Missouri

A patient moving to Missouri with an active flibanserin prescription from another state can transfer the prescription to a Missouri-licensed pharmacy. Because flibanserin is not a federally scheduled controlled substance, standard prescription transfer rules apply. [17]

The receiving Missouri pharmacy contacts the original dispensing pharmacy directly. Missouri law allows one transfer of a non-controlled prescription between pharmacies. Once transferred, the prescription can be refilled at the Missouri pharmacy for the remaining authorized refills up to one year from the original prescribe date.

If the original prescription has expired or lacks refills, the patient needs a new evaluation with a Missouri-licensed prescriber. A telehealth visit covering the patient's history, current medications, and alcohol use pattern satisfies this requirement and can result in a new Missouri prescription on the same day.

Out-of-state prescriptions presented directly at a Missouri pharmacy (without transfer) are legally valid in Missouri if the out-of-state prescriber holds a license in their home state and the prescription meets Missouri formatting requirements. The pharmacist has discretion to fill or decline based on professional judgment regarding the prescription's validity.

Managing Side Effects and Follow-Up in Missouri

The most common adverse effects of flibanserin are dizziness (11% of patients in trials), somnolence (11%), nausea (10%), and fatigue (9%), based on the prescribing information pooled trial data. [1] Most side effects are CNS-mediated and dose-timing dependent. Taking the dose at bedtime rather than earlier in the evening reduces next-morning sedation and dizziness. [1]

Hypotension with syncope risk is highest in the first few doses and when alcohol or CYP3A4 inhibitors are co-administered. [1] Patients should be counseled to rise slowly from bed the morning after the first dose and to avoid driving or operating machinery until they know how the drug affects them.

Missouri prescribers using telehealth for follow-up visits can assess tolerability via video or asynchronous messaging on HIPAA-compliant platforms. A structured four-week check-in covering sleep quality, dizziness, nausea, desire change, and SSE count tracks response efficiently. The FDA recommends discontinuing flibanserin if no benefit is seen after eight weeks of consistent nightly use. [1]

Sexual health outcomes data from a pooled analysis of three phase 3 trials (N=2,400) showed that women who continued flibanserin for 24 weeks reported a mean increase of 0.5 satisfying sexual events per month above the placebo-adjusted rate, with 47% of flibanserin-treated women rating themselves "much improved" or "very much improved" on the Patient Global Impression of Change versus 30% for placebo. [18]